Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hydrocortisone | 37 | 2010 | 1809 | 1.960 |
Why?
|
Pituitary-Adrenal System | 25 | 2010 | 552 | 1.960 |
Why?
|
Hypothalamo-Hypophyseal System | 16 | 2010 | 702 | 1.540 |
Why?
|
Depressive Disorder | 34 | 2012 | 3743 | 1.510 |
Why?
|
Antidepressive Agents, Second-Generation | 8 | 2013 | 503 | 1.410 |
Why?
|
Sleep, REM | 19 | 2013 | 594 | 1.270 |
Why?
|
Citalopram | 4 | 2013 | 404 | 1.040 |
Why?
|
Adrenocorticotropic Hormone | 21 | 2005 | 647 | 1.040 |
Why?
|
Corticosterone | 28 | 2006 | 309 | 1.020 |
Why?
|
Prolactin | 24 | 2005 | 668 | 1.020 |
Why?
|
Scopolamine | 7 | 2004 | 99 | 0.880 |
Why?
|
Depressive Disorder, Major | 11 | 2013 | 4606 | 0.870 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 6 | 2003 | 65 | 0.780 |
Why?
|
Dexamethasone | 21 | 1994 | 1948 | 0.720 |
Why?
|
Bupropion | 4 | 2013 | 303 | 0.720 |
Why?
|
Life Change Events | 4 | 2010 | 936 | 0.720 |
Why?
|
Nicotine | 7 | 2006 | 670 | 0.680 |
Why?
|
Desipramine | 6 | 2008 | 184 | 0.660 |
Why?
|
Phencyclidine | 9 | 2005 | 61 | 0.640 |
Why?
|
Antidepressive Agents | 7 | 2012 | 2836 | 0.520 |
Why?
|
Hallucinogens | 5 | 2003 | 180 | 0.510 |
Why?
|
Stress, Psychological | 8 | 2011 | 4212 | 0.490 |
Why?
|
Prenatal Exposure Delayed Effects | 16 | 2006 | 2393 | 0.470 |
Why?
|
Immobilization | 2 | 2004 | 236 | 0.450 |
Why?
|
Massage | 1 | 2012 | 85 | 0.430 |
Why?
|
Antidepressive Agents, Tricyclic | 4 | 2008 | 433 | 0.430 |
Why?
|
Sleep | 14 | 2013 | 4596 | 0.430 |
Why?
|
Muscarinic Antagonists | 3 | 2004 | 136 | 0.410 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2013 | 323 | 0.390 |
Why?
|
Social Support | 2 | 2011 | 2112 | 0.370 |
Why?
|
Sepsis | 5 | 2023 | 2571 | 0.370 |
Why?
|
Electroencephalography | 12 | 2009 | 6133 | 0.370 |
Why?
|
Rats | 49 | 2008 | 24270 | 0.360 |
Why?
|
Nicotinic Agonists | 2 | 2006 | 271 | 0.360 |
Why?
|
Social Environment | 3 | 2010 | 1014 | 0.350 |
Why?
|
Saliva | 9 | 2009 | 805 | 0.350 |
Why?
|
Pneumonia, Ventilator-Associated | 2 | 2023 | 274 | 0.340 |
Why?
|
Serotonin Agents | 2 | 2000 | 31 | 0.340 |
Why?
|
Rats, Sprague-Dawley | 19 | 2008 | 8299 | 0.330 |
Why?
|
Fatigue Syndrome, Chronic | 2 | 2001 | 214 | 0.320 |
Why?
|
Behavior, Animal | 5 | 2008 | 1891 | 0.320 |
Why?
|
Thyrotropin-Releasing Hormone | 6 | 1993 | 147 | 0.320 |
Why?
|
Circadian Rhythm | 21 | 2012 | 2614 | 0.320 |
Why?
|
Haloperidol | 8 | 1992 | 397 | 0.310 |
Why?
|
Hypothalamic Diseases | 1 | 2009 | 135 | 0.310 |
Why?
|
Radioimmunoassay | 11 | 2008 | 918 | 0.310 |
Why?
|
Mecamylamine | 2 | 2006 | 29 | 0.310 |
Why?
|
Dextromethorphan | 3 | 2004 | 38 | 0.300 |
Why?
|
Adrenergic Uptake Inhibitors | 2 | 2001 | 189 | 0.300 |
Why?
|
Nicotinic Antagonists | 2 | 2006 | 96 | 0.290 |
Why?
|
Receptors, Opioid | 6 | 1989 | 155 | 0.290 |
Why?
|
HIV Seropositivity | 1 | 2012 | 966 | 0.290 |
Why?
|
Digestive System Surgical Procedures | 2 | 2023 | 568 | 0.290 |
Why?
|
Mixed Function Oxygenases | 3 | 2006 | 272 | 0.280 |
Why?
|
Swimming | 2 | 2004 | 205 | 0.280 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2005 | 449 | 0.270 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2009 | 4220 | 0.270 |
Why?
|
Male | 124 | 2023 | 349022 | 0.270 |
Why?
|
Thyrotropin | 9 | 1993 | 849 | 0.270 |
Why?
|
Depression | 6 | 2012 | 7689 | 0.260 |
Why?
|
Allostasis | 1 | 2006 | 69 | 0.260 |
Why?
|
Pituitary Hormones, Anterior | 5 | 1985 | 65 | 0.260 |
Why?
|
Ganglionic Stimulants | 2 | 2003 | 19 | 0.250 |
Why?
|
Rats, Inbred Strains | 18 | 1991 | 2198 | 0.250 |
Why?
|
Mexican Americans | 4 | 2012 | 165 | 0.250 |
Why?
|
Dextrorphan | 1 | 2004 | 4 | 0.250 |
Why?
|
Levorphanol | 1 | 2004 | 10 | 0.250 |
Why?
|
Serotonin Receptor Agonists | 2 | 1996 | 153 | 0.250 |
Why?
|
Cues | 2 | 2006 | 865 | 0.240 |
Why?
|
Iodophors | 1 | 2023 | 7 | 0.240 |
Why?
|
Dose-Response Relationship, Drug | 18 | 2010 | 10945 | 0.240 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 2 | 2006 | 257 | 0.240 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2005 | 312 | 0.230 |
Why?
|
Stress, Physiological | 9 | 2003 | 1405 | 0.230 |
Why?
|
Adult | 84 | 2023 | 213394 | 0.230 |
Why?
|
Mothers | 2 | 2006 | 2143 | 0.230 |
Why?
|
Baths | 1 | 2023 | 54 | 0.230 |
Why?
|
Mupirocin | 1 | 2023 | 56 | 0.230 |
Why?
|
Cytochrome P-450 Enzyme System | 3 | 2001 | 419 | 0.230 |
Why?
|
Polysomnography | 8 | 2013 | 1765 | 0.230 |
Why?
|
Self Mutilation | 2 | 1995 | 58 | 0.230 |
Why?
|
Interpersonal Relations | 1 | 2011 | 1421 | 0.220 |
Why?
|
Cross Infection | 3 | 2023 | 1414 | 0.220 |
Why?
|
Dopamine Agonists | 1 | 2005 | 355 | 0.220 |
Why?
|
Aspartic Acid | 3 | 2001 | 575 | 0.220 |
Why?
|
Female | 94 | 2023 | 378853 | 0.220 |
Why?
|
Sleep Stages | 11 | 2013 | 686 | 0.210 |
Why?
|
Pituitary Gland, Anterior | 4 | 1989 | 177 | 0.210 |
Why?
|
Mental Processes | 1 | 2003 | 249 | 0.210 |
Why?
|
Chlorhexidine | 1 | 2023 | 161 | 0.210 |
Why?
|
Catecholamines | 2 | 2002 | 387 | 0.210 |
Why?
|
Analysis of Variance | 10 | 2006 | 6370 | 0.200 |
Why?
|
Growth Hormone | 12 | 1991 | 703 | 0.200 |
Why?
|
Fludrocortisone | 1 | 2001 | 25 | 0.200 |
Why?
|
Sleep Deprivation | 3 | 2004 | 831 | 0.200 |
Why?
|
Mineralocorticoids | 1 | 2001 | 39 | 0.200 |
Why?
|
Brain Chemistry | 5 | 1999 | 985 | 0.200 |
Why?
|
Serotonin | 4 | 2003 | 1022 | 0.190 |
Why?
|
Ethanol | 7 | 2004 | 1329 | 0.190 |
Why?
|
Adolescent Behavior | 1 | 2009 | 1146 | 0.190 |
Why?
|
Coumarins | 1 | 2000 | 120 | 0.190 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 895 | 0.180 |
Why?
|
Humans | 126 | 2023 | 739398 | 0.180 |
Why?
|
Smoking | 3 | 2009 | 8960 | 0.180 |
Why?
|
Buspirone | 1 | 2000 | 82 | 0.180 |
Why?
|
Mydriatics | 1 | 1999 | 68 | 0.180 |
Why?
|
Amitriptyline | 2 | 1991 | 108 | 0.170 |
Why?
|
Psychiatric Status Rating Scales | 13 | 2004 | 6028 | 0.170 |
Why?
|
Vital Signs | 1 | 2020 | 141 | 0.170 |
Why?
|
Catheter-Related Infections | 1 | 2022 | 253 | 0.170 |
Why?
|
Genotype | 3 | 2013 | 12951 | 0.170 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2023 | 694 | 0.170 |
Why?
|
Dibenzocycloheptenes | 2 | 1989 | 27 | 0.170 |
Why?
|
Neuroprotective Agents | 1 | 2005 | 940 | 0.170 |
Why?
|
Buprenorphine | 2 | 2023 | 634 | 0.170 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2023 | 629 | 0.170 |
Why?
|
8-Hydroxy-2-(di-n-propylamino)tetralin | 2 | 1996 | 32 | 0.160 |
Why?
|
Dizocilpine Maleate | 3 | 1995 | 176 | 0.160 |
Why?
|
Substance-Related Disorders | 3 | 2009 | 4239 | 0.160 |
Why?
|
Arousal | 4 | 2010 | 1164 | 0.160 |
Why?
|
Middle Aged | 48 | 2023 | 212863 | 0.160 |
Why?
|
Hospitalization | 8 | 2022 | 10208 | 0.160 |
Why?
|
Morpholines | 1 | 2001 | 562 | 0.160 |
Why?
|
Survivors | 2 | 2006 | 2280 | 0.160 |
Why?
|
Hypotension, Orthostatic | 1 | 2001 | 258 | 0.160 |
Why?
|
Interleukin-6 | 2 | 2006 | 3194 | 0.150 |
Why?
|
Myotonic Dystrophy | 1 | 1998 | 78 | 0.150 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2001 | 3757 | 0.150 |
Why?
|
Fenfluramine | 1 | 1997 | 60 | 0.150 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2021 | 459 | 0.150 |
Why?
|
Psychomotor Performance | 2 | 2003 | 1899 | 0.150 |
Why?
|
Receptors, sigma | 3 | 1994 | 28 | 0.150 |
Why?
|
Carbapenems | 1 | 2018 | 114 | 0.150 |
Why?
|
Trinucleotide Repeats | 1 | 1998 | 261 | 0.150 |
Why?
|
Hydroxychloroquine | 1 | 2021 | 407 | 0.150 |
Why?
|
Cytochrome P-450 CYP2D6 | 3 | 2001 | 106 | 0.140 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2021 | 439 | 0.140 |
Why?
|
Adolescent | 23 | 2021 | 85405 | 0.140 |
Why?
|
Multiple Organ Failure | 1 | 2019 | 385 | 0.140 |
Why?
|
Metalloporphyrins | 1 | 2016 | 40 | 0.140 |
Why?
|
Receptors, Cholinergic | 1 | 1997 | 238 | 0.140 |
Why?
|
United States Food and Drug Administration | 2 | 2021 | 1584 | 0.140 |
Why?
|
Hyperbilirubinemia, Neonatal | 1 | 2016 | 24 | 0.140 |
Why?
|
Urinary Tract Infections | 1 | 2022 | 766 | 0.140 |
Why?
|
Reaction Time | 4 | 2002 | 2097 | 0.140 |
Why?
|
Gene Deletion | 1 | 2004 | 2757 | 0.140 |
Why?
|
Anti-Infective Agents | 1 | 2023 | 973 | 0.140 |
Why?
|
Cross-Over Studies | 5 | 2013 | 2030 | 0.140 |
Why?
|
Naloxone | 3 | 1989 | 367 | 0.140 |
Why?
|
Hospitals | 7 | 2023 | 3916 | 0.140 |
Why?
|
Animals | 54 | 2008 | 168368 | 0.130 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2016 | 171 | 0.130 |
Why?
|
Brain | 14 | 2004 | 26345 | 0.130 |
Why?
|
Awards and Prizes | 1 | 2020 | 375 | 0.130 |
Why?
|
Pemoline | 1 | 1995 | 18 | 0.130 |
Why?
|
Testosterone | 9 | 2003 | 2391 | 0.130 |
Why?
|
Phenelzine | 1 | 1995 | 28 | 0.130 |
Why?
|
Endocrine Glands | 2 | 1987 | 102 | 0.130 |
Why?
|
Bacteremia | 1 | 2022 | 957 | 0.130 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2000 | 1129 | 0.130 |
Why?
|
Receptors, Neurotransmitter | 4 | 1990 | 178 | 0.130 |
Why?
|
Imipramine | 2 | 2000 | 97 | 0.130 |
Why?
|
Anti-Anxiety Agents | 2 | 1997 | 390 | 0.120 |
Why?
|
Staphylococcal Infections | 1 | 2023 | 1403 | 0.120 |
Why?
|
Blood Transfusion | 1 | 2021 | 1296 | 0.120 |
Why?
|
Norepinephrine | 4 | 2006 | 910 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 2 | 2006 | 1777 | 0.120 |
Why?
|
Bilirubin | 1 | 2016 | 415 | 0.120 |
Why?
|
Medicare | 2 | 2023 | 6497 | 0.120 |
Why?
|
Luteinizing Hormone | 10 | 1989 | 865 | 0.110 |
Why?
|
Conditioning, Operant | 2 | 2006 | 314 | 0.110 |
Why?
|
Therapeutic Touch | 1 | 2012 | 8 | 0.110 |
Why?
|
Age Factors | 10 | 2020 | 18349 | 0.110 |
Why?
|
Proton Pump Inhibitors | 1 | 2018 | 519 | 0.110 |
Why?
|
Epinephrine | 3 | 2006 | 795 | 0.110 |
Why?
|
Sexual Maturation | 1 | 1995 | 265 | 0.110 |
Why?
|
Extinction, Psychological | 2 | 2006 | 375 | 0.110 |
Why?
|
Hippocampus | 3 | 2003 | 3657 | 0.110 |
Why?
|
Hyperglycemia | 1 | 2021 | 1357 | 0.110 |
Why?
|
United States | 17 | 2023 | 69573 | 0.110 |
Why?
|
Piperazines | 2 | 1995 | 2480 | 0.110 |
Why?
|
Double-Blind Method | 8 | 2013 | 11985 | 0.110 |
Why?
|
Postpartum Period | 1 | 1999 | 1070 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1197 | 0.110 |
Why?
|
Frontal Lobe | 1 | 1999 | 1409 | 0.100 |
Why?
|
Self Administration | 4 | 2006 | 386 | 0.100 |
Why?
|
Suicide, Attempted | 1 | 2020 | 1213 | 0.100 |
Why?
|
Nialamide | 1 | 1991 | 6 | 0.100 |
Why?
|
Clostridium Infections | 1 | 2018 | 549 | 0.100 |
Why?
|
3,4-Methylenedioxyamphetamine | 1 | 1990 | 2 | 0.100 |
Why?
|
Morphine | 5 | 1986 | 655 | 0.100 |
Why?
|
Electronic Health Records | 4 | 2021 | 4426 | 0.100 |
Why?
|
Benzodiazepines | 2 | 1997 | 1099 | 0.100 |
Why?
|
Cross-Cultural Comparison | 4 | 2012 | 648 | 0.100 |
Why?
|
Gene Frequency | 4 | 2013 | 3585 | 0.090 |
Why?
|
Neuropsychological Tests | 1 | 2003 | 6963 | 0.090 |
Why?
|
Tetrahydronaphthalenes | 1 | 1990 | 90 | 0.090 |
Why?
|
Injections, Subcutaneous | 5 | 1994 | 664 | 0.090 |
Why?
|
Cocaine | 4 | 2005 | 1008 | 0.090 |
Why?
|
Hospital Mortality | 5 | 2022 | 5305 | 0.090 |
Why?
|
Serotonin Antagonists | 1 | 1990 | 146 | 0.090 |
Why?
|
Influenza, Human | 1 | 2021 | 1476 | 0.090 |
Why?
|
Cerebrovascular Circulation | 2 | 2000 | 2757 | 0.090 |
Why?
|
Deamino Arginine Vasopressin | 1 | 1990 | 91 | 0.090 |
Why?
|
Inositol | 3 | 1999 | 216 | 0.090 |
Why?
|
Aged | 26 | 2023 | 162698 | 0.090 |
Why?
|
Mental Disorders | 4 | 1999 | 6570 | 0.080 |
Why?
|
Somatoform Disorders | 1 | 2012 | 422 | 0.080 |
Why?
|
Phencyclidine Abuse | 1 | 1988 | 8 | 0.080 |
Why?
|
Electromyography | 3 | 2004 | 1389 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1828 | 0.080 |
Why?
|
Pregnancy | 20 | 2006 | 29002 | 0.080 |
Why?
|
Choline | 3 | 1999 | 488 | 0.080 |
Why?
|
Saccharin | 2 | 1987 | 20 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 2059 | 0.080 |
Why?
|
Leukemia Inhibitory Factor | 2 | 2006 | 61 | 0.080 |
Why?
|
Alprazolam | 1 | 1988 | 98 | 0.080 |
Why?
|
Drug Interactions | 5 | 2000 | 1456 | 0.080 |
Why?
|
Risk Factors | 9 | 2021 | 71974 | 0.080 |
Why?
|
Retrospective Studies | 11 | 2023 | 76631 | 0.070 |
Why?
|
Codeine | 1 | 1987 | 49 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3233 | 0.070 |
Why?
|
Blood Glucose | 1 | 2021 | 6237 | 0.070 |
Why?
|
Drug Administration Schedule | 3 | 2011 | 4935 | 0.070 |
Why?
|
Receptors, Phencyclidine | 4 | 1990 | 13 | 0.070 |
Why?
|
Prisoners | 1 | 1990 | 297 | 0.070 |
Why?
|
Psychology | 1 | 2008 | 351 | 0.070 |
Why?
|
Infant, Premature | 1 | 2016 | 2039 | 0.070 |
Why?
|
Receptors, Nicotinic | 2 | 2003 | 496 | 0.070 |
Why?
|
Mental Health | 1 | 2020 | 2946 | 0.070 |
Why?
|
Morphinans | 1 | 1985 | 31 | 0.070 |
Why?
|
Aged, 80 and over | 8 | 2023 | 57650 | 0.070 |
Why?
|
Placebos | 2 | 2005 | 1678 | 0.070 |
Why?
|
Reference Values | 5 | 1999 | 4983 | 0.070 |
Why?
|
Lithium | 2 | 1988 | 603 | 0.070 |
Why?
|
Phenazocine | 3 | 1994 | 7 | 0.070 |
Why?
|
Schizophrenic Psychology | 2 | 1992 | 1677 | 0.070 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 2006 | 369 | 0.070 |
Why?
|
Azocines | 1 | 1985 | 18 | 0.070 |
Why?
|
Anticoagulants | 1 | 2000 | 4582 | 0.070 |
Why?
|
Neoplasms | 2 | 2006 | 21507 | 0.060 |
Why?
|
Dehydroepiandrosterone | 1 | 2006 | 252 | 0.060 |
Why?
|
Disease Models, Animal | 6 | 2005 | 18003 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2012 | 15511 | 0.060 |
Why?
|
Recurrence | 3 | 2010 | 8307 | 0.060 |
Why?
|
Animals, Newborn | 4 | 1986 | 2732 | 0.060 |
Why?
|
Schizophrenia | 5 | 1992 | 6866 | 0.060 |
Why?
|
Minority Groups | 1 | 2012 | 1197 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7136 | 0.060 |
Why?
|
Family Health | 1 | 2009 | 1281 | 0.060 |
Why?
|
Narcotic Antagonists | 2 | 1989 | 562 | 0.060 |
Why?
|
Binding, Competitive | 1 | 2005 | 1158 | 0.060 |
Why?
|
ROC Curve | 2 | 1990 | 3526 | 0.060 |
Why?
|
Chronic Disease | 2 | 2010 | 9133 | 0.060 |
Why?
|
Food Preferences | 2 | 1987 | 398 | 0.060 |
Why?
|
Association Learning | 1 | 2005 | 224 | 0.060 |
Why?
|
Aging | 3 | 1999 | 8613 | 0.060 |
Why?
|
Antipsychotic Agents | 3 | 1995 | 3055 | 0.060 |
Why?
|
Demography | 1 | 2008 | 1650 | 0.060 |
Why?
|
Polymorphism, Genetic | 3 | 2006 | 4332 | 0.060 |
Why?
|
Adjustment Disorders | 1 | 1983 | 70 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5702 | 0.050 |
Why?
|
Exploratory Behavior | 1 | 2004 | 270 | 0.050 |
Why?
|
Physical Stimulation | 1 | 2004 | 526 | 0.050 |
Why?
|
Intelligence Tests | 1 | 2003 | 505 | 0.050 |
Why?
|
Surgical Wound Infection | 2 | 2023 | 1530 | 0.050 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2012 | 1338 | 0.050 |
Why?
|
Causality | 1 | 2009 | 1262 | 0.050 |
Why?
|
Administration, Intranasal | 1 | 2023 | 445 | 0.050 |
Why?
|
Maze Learning | 1 | 2004 | 478 | 0.050 |
Why?
|
Azetidines | 1 | 2003 | 142 | 0.050 |
Why?
|
Time Factors | 6 | 2013 | 40050 | 0.050 |
Why?
|
Psychotropic Drugs | 5 | 1991 | 891 | 0.050 |
Why?
|
Electronics | 1 | 2023 | 322 | 0.050 |
Why?
|
Endotoxins | 1 | 2004 | 524 | 0.050 |
Why?
|
Anti-Infective Agents, Local | 1 | 2023 | 248 | 0.050 |
Why?
|
Genetics, Population | 1 | 2006 | 931 | 0.050 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2001 | 115 | 0.050 |
Why?
|
Military Personnel | 1 | 1990 | 1119 | 0.050 |
Why?
|
Virginia | 1 | 2020 | 121 | 0.050 |
Why?
|
Anxiety Disorders | 3 | 2009 | 2674 | 0.050 |
Why?
|
Extracellular Space | 1 | 2003 | 594 | 0.050 |
Why?
|
Alcoholic Intoxication | 1 | 1982 | 188 | 0.050 |
Why?
|
Delayed-Action Preparations | 1 | 2004 | 962 | 0.050 |
Why?
|
Technetium Tc 99m Exametazime | 1 | 2000 | 71 | 0.050 |
Why?
|
Nervous System | 1 | 1984 | 557 | 0.050 |
Why?
|
Cyclohexanols | 1 | 2000 | 127 | 0.050 |
Why?
|
Memory | 1 | 1990 | 2161 | 0.050 |
Why?
|
Creatine | 2 | 1999 | 422 | 0.050 |
Why?
|
Tobacco Use Disorder | 1 | 2005 | 682 | 0.040 |
Why?
|
Area Under Curve | 2 | 2001 | 1655 | 0.040 |
Why?
|
Inpatients | 2 | 2021 | 2478 | 0.040 |
Why?
|
Azithromycin | 1 | 2021 | 194 | 0.040 |
Why?
|
Anticonvulsants | 1 | 1989 | 1907 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2023 | 3672 | 0.040 |
Why?
|
California | 2 | 2001 | 1400 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2012 | 3279 | 0.040 |
Why?
|
Child | 8 | 2023 | 77033 | 0.040 |
Why?
|
Opiate Substitution Treatment | 1 | 2023 | 399 | 0.040 |
Why?
|
Disease Progression | 2 | 2021 | 13237 | 0.040 |
Why?
|
Antiviral Agents | 2 | 2021 | 2971 | 0.040 |
Why?
|
Pituitary Hormones | 1 | 1980 | 183 | 0.040 |
Why?
|
Biological Assay | 2 | 1994 | 653 | 0.040 |
Why?
|
Adrenal Glands | 3 | 1989 | 545 | 0.040 |
Why?
|
Intelligence | 1 | 2003 | 919 | 0.040 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 1998 | 36 | 0.040 |
Why?
|
Alkaloids | 1 | 1999 | 189 | 0.040 |
Why?
|
Hospitals, Community | 1 | 2020 | 347 | 0.040 |
Why?
|
Behavior, Addictive | 1 | 2004 | 460 | 0.040 |
Why?
|
Hormones | 3 | 1996 | 880 | 0.040 |
Why?
|
Cholesterol | 2 | 2006 | 2900 | 0.040 |
Why?
|
Administration, Oral | 2 | 2000 | 3909 | 0.040 |
Why?
|
Sample Size | 1 | 2001 | 845 | 0.040 |
Why?
|
Narcotics | 1 | 2000 | 343 | 0.040 |
Why?
|
Sex Factors | 6 | 2004 | 10398 | 0.040 |
Why?
|
Alcohol Dehydrogenase | 1 | 1998 | 119 | 0.040 |
Why?
|
Motor Activity | 2 | 2006 | 2719 | 0.040 |
Why?
|
Computers | 1 | 2020 | 614 | 0.040 |
Why?
|
Odds Ratio | 2 | 2021 | 9846 | 0.040 |
Why?
|
Pandemics | 3 | 2022 | 8274 | 0.040 |
Why?
|
Aldehyde Dehydrogenase | 1 | 1998 | 141 | 0.040 |
Why?
|
Wakefulness | 1 | 2004 | 1241 | 0.040 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 1996 | 90 | 0.040 |
Why?
|
Observation | 1 | 1999 | 312 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8275 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2009 | 38942 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1998 | 769 | 0.040 |
Why?
|
Follicle Stimulating Hormone | 4 | 1989 | 739 | 0.040 |
Why?
|
Binding Sites | 1 | 2005 | 6113 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2001 | 35326 | 0.040 |
Why?
|
Secretory Rate | 2 | 1986 | 82 | 0.040 |
Why?
|
Creatinine | 2 | 2001 | 1903 | 0.030 |
Why?
|
Blood Proteins | 1 | 2001 | 1122 | 0.030 |
Why?
|
Panic | 2 | 1985 | 106 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7690 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2003 | 21694 | 0.030 |
Why?
|
Motivation | 1 | 2005 | 1965 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2012 | 62693 | 0.030 |
Why?
|
Young Adult | 5 | 2021 | 56255 | 0.030 |
Why?
|
Cyclazocine | 2 | 1985 | 10 | 0.030 |
Why?
|
Ethylketocyclazocine | 2 | 1985 | 4 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2021 | 867 | 0.030 |
Why?
|
Protons | 2 | 1998 | 1124 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2023 | 1449 | 0.030 |
Why?
|
Cortisone | 1 | 1995 | 89 | 0.030 |
Why?
|
Sympathomimetics | 1 | 1994 | 57 | 0.030 |
Why?
|
Dioxolanes | 1 | 1994 | 25 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 3 | 1990 | 1187 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2010 | 13880 | 0.030 |
Why?
|
Depression, Chemical | 1 | 1994 | 191 | 0.030 |
Why?
|
Comorbidity | 1 | 2009 | 10362 | 0.030 |
Why?
|
Language | 1 | 2003 | 1447 | 0.030 |
Why?
|
Alcohol Drinking | 2 | 2004 | 3945 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 853 | 0.030 |
Why?
|
Bites and Stings | 1 | 1995 | 90 | 0.030 |
Why?
|
Benzodiazepinones | 1 | 1973 | 51 | 0.030 |
Why?
|
Alleles | 3 | 2001 | 6942 | 0.030 |
Why?
|
Stereoisomerism | 1 | 1994 | 628 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15036 | 0.030 |
Why?
|
Injections, Intravenous | 2 | 2003 | 1421 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1996 | 1676 | 0.030 |
Why?
|
Vanilmandelic Acid | 1 | 1972 | 17 | 0.030 |
Why?
|
17-Hydroxycorticosteroids | 1 | 1972 | 40 | 0.030 |
Why?
|
Isoenzymes | 1 | 1998 | 1720 | 0.030 |
Why?
|
Phototherapy | 1 | 2016 | 372 | 0.030 |
Why?
|
Patient Admission | 1 | 2020 | 1383 | 0.030 |
Why?
|
Colon | 1 | 2021 | 1771 | 0.030 |
Why?
|
Pregnancy Complications | 3 | 1999 | 2867 | 0.030 |
Why?
|
Lesch-Nyhan Syndrome | 1 | 1991 | 14 | 0.030 |
Why?
|
Aggression | 1 | 1996 | 753 | 0.030 |
Why?
|
Blood Pressure | 2 | 2006 | 8554 | 0.030 |
Why?
|
Infant | 2 | 2021 | 34923 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 1996 | 679 | 0.030 |
Why?
|
Pyridines | 1 | 2003 | 2810 | 0.030 |
Why?
|
Drug Synergism | 1 | 1996 | 1792 | 0.020 |
Why?
|
Hypothalamus | 1 | 1997 | 1066 | 0.020 |
Why?
|
Neonatal Screening | 1 | 2016 | 591 | 0.020 |
Why?
|
Institutionalization | 1 | 1991 | 104 | 0.020 |
Why?
|
Suicidal Ideation | 1 | 2020 | 1236 | 0.020 |
Why?
|
Compulsive Behavior | 1 | 1991 | 115 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 40802 | 0.020 |
Why?
|
Thyroxine | 2 | 1987 | 666 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 1991 | 423 | 0.020 |
Why?
|
Personality Tests | 1 | 1990 | 83 | 0.020 |
Why?
|
MMPI | 1 | 1990 | 86 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3286 | 0.020 |
Why?
|
Psychotic Disorders | 1 | 1985 | 3028 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2000 | 2687 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2560 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 40389 | 0.020 |
Why?
|
Organ Size | 2 | 1987 | 2247 | 0.020 |
Why?
|
Psychopharmacology | 1 | 1991 | 143 | 0.020 |
Why?
|
Scotland | 1 | 1989 | 155 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2004 | 14558 | 0.020 |
Why?
|
Oxygen | 1 | 2020 | 4158 | 0.020 |
Why?
|
Injections, Intraventricular | 1 | 1989 | 232 | 0.020 |
Why?
|
Protein Binding | 1 | 2001 | 9375 | 0.020 |
Why?
|
Brain Diseases | 1 | 1998 | 1551 | 0.020 |
Why?
|
Receptors, Muscarinic | 1 | 1989 | 156 | 0.020 |
Why?
|
Health Policy | 1 | 2021 | 2655 | 0.020 |
Why?
|
Stimulation, Chemical | 2 | 1986 | 326 | 0.020 |
Why?
|
Body Weight | 5 | 1996 | 4660 | 0.020 |
Why?
|
Central Nervous System | 1 | 1996 | 1362 | 0.020 |
Why?
|
Cushing Syndrome | 1 | 1990 | 249 | 0.020 |
Why?
|
Body Mass Index | 1 | 2006 | 12655 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 1995 | 1310 | 0.020 |
Why?
|
Pineal Gland | 1 | 1989 | 165 | 0.020 |
Why?
|
Electroshock | 2 | 1986 | 121 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15070 | 0.020 |
Why?
|
Analgesics | 1 | 1994 | 1034 | 0.020 |
Why?
|
Prospective Studies | 3 | 2010 | 53037 | 0.020 |
Why?
|
Alcoholism | 1 | 1998 | 1892 | 0.020 |
Why?
|
Indians, North American | 1 | 1991 | 352 | 0.020 |
Why?
|
Iran | 1 | 1990 | 700 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12761 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2023 | 3650 | 0.020 |
Why?
|
Piperidines | 1 | 1994 | 1597 | 0.020 |
Why?
|
Los Angeles | 1 | 2006 | 236 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 21863 | 0.020 |
Why?
|
Heart Rate | 2 | 2013 | 4095 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1987 | 683 | 0.020 |
Why?
|
Reinforcement Schedule | 1 | 2005 | 129 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2003 | 1580 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13402 | 0.020 |
Why?
|
Clonidine | 1 | 1986 | 164 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 1973 | 1158 | 0.020 |
Why?
|
Disorders of Sex Development | 1 | 1986 | 120 | 0.020 |
Why?
|
Endorphins | 2 | 1986 | 75 | 0.020 |
Why?
|
Triiodothyronine | 1 | 1987 | 491 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15153 | 0.020 |
Why?
|
Vasopressins | 2 | 1978 | 370 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20913 | 0.020 |
Why?
|
Thyroid Gland | 2 | 1989 | 1169 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2021 | 9259 | 0.020 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 1986 | 187 | 0.020 |
Why?
|
Propranolol | 1 | 1986 | 499 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5272 | 0.010 |
Why?
|
Melatonin | 1 | 1989 | 719 | 0.010 |
Why?
|
Electrochemistry | 1 | 2003 | 145 | 0.010 |
Why?
|
Microdialysis | 1 | 2003 | 158 | 0.010 |
Why?
|
Antitussive Agents | 1 | 2001 | 17 | 0.010 |
Why?
|
African Americans | 1 | 2001 | 23 | 0.010 |
Why?
|
Chromatography, Gas | 1 | 1981 | 156 | 0.010 |
Why?
|
Bipolar Disorder | 3 | 1990 | 5023 | 0.010 |
Why?
|
Sex Characteristics | 2 | 1995 | 2583 | 0.010 |
Why?
|
Submandibular Gland | 1 | 1981 | 86 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6478 | 0.010 |
Why?
|
Hypothermia | 1 | 1983 | 188 | 0.010 |
Why?
|
Phenotype | 3 | 2006 | 16301 | 0.010 |
Why?
|
Estradiol | 1 | 1989 | 2021 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9684 | 0.010 |
Why?
|
Mice | 3 | 2006 | 81002 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1997 | 5721 | 0.010 |
Why?
|
Family | 1 | 1991 | 3141 | 0.010 |
Why?
|
Gene Duplication | 1 | 2001 | 330 | 0.010 |
Why?
|
Heart | 1 | 2013 | 4466 | 0.010 |
Why?
|
Electrocardiography | 1 | 2013 | 6426 | 0.010 |
Why?
|
Eating | 1 | 1987 | 1526 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13872 | 0.010 |
Why?
|
Ion Exchange Resins | 1 | 1978 | 7 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 2257 | 0.010 |
Why?
|
Anion Exchange Resins | 1 | 1978 | 10 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 24714 | 0.010 |
Why?
|
Trichloroacetic Acid | 1 | 1978 | 34 | 0.010 |
Why?
|
Analgesia | 1 | 1984 | 458 | 0.010 |
Why?
|
China | 1 | 1985 | 2225 | 0.010 |
Why?
|
Glucocorticoids | 1 | 1988 | 2100 | 0.010 |
Why?
|
Talc | 1 | 1978 | 47 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 1981 | 706 | 0.010 |
Why?
|
Asia | 2 | 1991 | 604 | 0.010 |
Why?
|
Nerve Growth Factors | 1 | 1981 | 578 | 0.010 |
Why?
|
Half-Life | 1 | 1999 | 658 | 0.010 |
Why?
|
Pituitary Gland | 2 | 1987 | 667 | 0.010 |
Why?
|
Regression Analysis | 1 | 1988 | 6452 | 0.010 |
Why?
|
Methadone | 1 | 1980 | 307 | 0.010 |
Why?
|
Peptides | 2 | 1981 | 4395 | 0.010 |
Why?
|
Anxiety | 1 | 2012 | 4253 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1998 | 475 | 0.010 |
Why?
|
Social Dominance | 1 | 1996 | 38 | 0.010 |
Why?
|
Fear | 1 | 1985 | 1430 | 0.010 |
Why?
|
Water-Electrolyte Balance | 1 | 1978 | 345 | 0.010 |
Why?
|
Affective Symptoms | 1 | 1999 | 406 | 0.010 |
Why?
|
Psychological Tests | 2 | 1989 | 649 | 0.010 |
Why?
|
Ligands | 1 | 2003 | 3311 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2016 | 25470 | 0.010 |
Why?
|
Telemetry | 1 | 1996 | 204 | 0.010 |
Why?
|
Length of Stay | 1 | 1989 | 6295 | 0.010 |
Why?
|
Rabbits | 1 | 1981 | 4882 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2000 | 2270 | 0.010 |
Why?
|
Patient Readmission | 1 | 1989 | 3106 | 0.010 |
Why?
|
Body Water | 1 | 1996 | 342 | 0.010 |
Why?
|
Kidney | 1 | 1990 | 7144 | 0.010 |
Why?
|
Flurazepam | 1 | 1973 | 8 | 0.010 |
Why?
|
Genetic Variation | 1 | 2009 | 6539 | 0.010 |
Why?
|
Diffusion | 1 | 1995 | 832 | 0.010 |
Why?
|
Aldosterone | 1 | 1978 | 870 | 0.010 |
Why?
|
Models, Statistical | 1 | 1988 | 5113 | 0.010 |
Why?
|
Gene Expression | 1 | 2006 | 7788 | 0.010 |
Why?
|
Glutamine | 1 | 1996 | 574 | 0.010 |
Why?
|
Body Temperature | 1 | 1996 | 775 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 1990 | 12948 | 0.010 |
Why?
|
Glycols | 1 | 1970 | 55 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2006 | 13002 | 0.010 |
Why?
|
Aerospace Medicine | 1 | 1970 | 82 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1996 | 2384 | 0.010 |
Why?
|
Glutamic Acid | 1 | 1996 | 1168 | 0.010 |
Why?
|
Periodicity | 1 | 1991 | 365 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1976 | 2373 | 0.010 |
Why?
|
Basal Ganglia Diseases | 1 | 1989 | 149 | 0.010 |
Why?
|
Emigration and Immigration | 1 | 1991 | 402 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1989 | 376 | 0.000 |
Why?
|
DNA | 1 | 2001 | 7275 | 0.000 |
Why?
|
Professional-Family Relations | 1 | 1991 | 481 | 0.000 |
Why?
|
Suicide | 1 | 1997 | 1469 | 0.000 |
Why?
|
Thyroid Hormones | 1 | 1989 | 387 | 0.000 |
Why?
|
Kinetics | 2 | 1986 | 6475 | 0.000 |
Why?
|
Agoraphobia | 1 | 1985 | 179 | 0.000 |
Why?
|
Uric Acid | 1 | 1971 | 753 | 0.000 |
Why?
|
Personality Inventory | 1 | 1987 | 1026 | 0.000 |
Why?
|
Sodium | 2 | 1978 | 1625 | 0.000 |
Why?
|
Pharmaceutical Vehicles | 1 | 1980 | 59 | 0.000 |
Why?
|
Caregivers | 1 | 1991 | 2067 | 0.000 |
Why?
|
Synaptic Transmission | 1 | 1986 | 1177 | 0.000 |
Why?
|
Chemical Precipitation | 1 | 1978 | 180 | 0.000 |
Why?
|
Adsorption | 1 | 1978 | 201 | 0.000 |
Why?
|
Isotope Labeling | 1 | 1978 | 415 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1972 | 7897 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1987 | 2711 | 0.000 |
Why?
|
Learning | 1 | 1986 | 1695 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 1998 | 17384 | 0.000 |
Why?
|
Iodine Radioisotopes | 1 | 1978 | 1031 | 0.000 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1980 | 1374 | 0.000 |
Why?
|
Naval Medicine | 1 | 1971 | 31 | 0.000 |
Why?
|
Diving | 1 | 1971 | 39 | 0.000 |
Why?
|
Pain | 1 | 1986 | 4923 | 0.000 |
Why?
|
Sampling Studies | 1 | 1971 | 624 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1990 | 20055 | 0.000 |
Why?
|